NCT05669313View on ClinicalTrials.gov

The Effects of Hypothermia and Acidosis on Coagulation During Treatment With Rivaroxaban Measured With ROTEM

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

September 4, 2022

Primary Completion Date

November 10, 2022

Study Completion Date

November 10, 2022

Conditions
TraumaHypothermiaAcidosisBleeding
Interventions
DRUG

Rivaroxaban 15 MG

Rivaroxaban 15 mg after inclusion and on the morning after inclusion, i.e., before blood sampling

Trial Locations (1)

22185

Skåne University Hospital, Lund

All Listed Sponsors
lead

Thomas Kander

OTHER